We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Welcome to our newest Industry Voice Podcast Series episode. This video is an insightful interview with Lee Smith Adageng from a leading Chinese biopharmaceutical company Staidson, focusing on their innovative therapeutics for bleeding disorders. Watch this episode to learn about the company’s international market strategies, drug development progress, and the role of Clinical Research Organizations in Staidson’s clinical trials
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
